EGCG: A POTENTIAL PHARMACOLOGICAL COMPOUND
Somya Maddheshiya* and Dr. Maneesh Jaiswal
ABSTRACT
The emergence of new ailments such as obesity, diabetes, cancer, heart disease, and neurological disorders has left society with a significant health issue. Investments in materials that improve public health are therefore crucial. In this case, a flavonoid called epigallocatechin gallate (EGCG) is present in a variety of plants, including tea. Numerous researches back up the idea that EGCG helps prevent obesity, diabetes, heart disease, cancer, and other ailments. Consuming tea catechins over an extended period of time may help prevent obesity, type II diabetes, and heart disease caused by high-fat diets. It is necessary to do more research that complies with worldwide requirements in order to track the pharmacological and therapeutic properties of green tea as well as to clarify how it works. However, the primary disadvantage of using EGCG in preventive and treatment is its low intestine absorption and volatility. The encapsulation of EGCG into nanocarriers results in an increase in its therapeutic benefits and stability. There will be a thorough analysis of all the research that are now accessible on EGCG encapsulation using nanocarriers.
[Full Text Article] [Download Certificate]